BIOCRYST PHARMACEUTICALS INC (BCRX) insider trading

Insider

Date

Role

Action

Shares

Price

Amount

Alan G Levin

30 May 2024

Director

Buy

7,861

$6.36

$50.00K

Steve Aselage

24 May 2024

Director

Buy indirect

2,500

$6.40

$16.00K

Vincent Milano

20 May 2024

Director

Buy

15,000

$6.25

$93.75K

Nancy J Hutson

20 May 2024

Director

Buy

5,000

$6.38

$31.90K

Helen M. Thackray

14 May 2024

Chief R&D Officer

Buy

30,000

$5.86

$175.80K

Anthony Doyle

14 May 2024

Chief Financial Officer

Buy

36,300

$5.57

$202.19K

Charles K Gayer

13 May 2024

Chief Commercial Officer

Buy

30,000

$5.47

$164.10K

Jon P Stonehouse

13 May 2024

President & CEO

Buy

30,000

$5.55

$166.50K

Alane P Barnes

13 May 2024

Chief Legal Officer

Buy

5,000

$5.53

$27.65K

Steven K Galson

13 May 2024

Director

Buy

21,940

$5.49

$120.45K

Vincent Milano

24 Nov 2021

Director

Buy

7,500

$12.19

$91.43K

Anthony Doyle

23 Nov 2021

Chief Financial Officer

Buy

35,258

$12.48

$440.02K

Anthony Doyle

11 Aug 2020

Chief Financial Officer

Buy

54,000

$4.08

$220.32K

Steve Aselage

18 Nov 2019

Director

Buy

15,000

$1.45

$21.75K

Yarlagadda S Babu

18 Nov 2019

Senior VP - Drug Discovery

Buy

25,000

$1.45

$36.25K

Alane P Barnes

18 Nov 2019

Senior VP, Chief Legal Officer

Buy

20,000

$1.45

$29.00K

Theresa Heggie

18 Nov 2019

Director

Buy

5,000

$1.45

$7.25K

Nancy J Hutson

18 Nov 2019

Director

Buy

10,000

$1.45

$14.50K

Robert Alexander Ingram

18 Nov 2019

Director

Buy

20,000

$1.45

$29.00K

Kenneth B Lee Jr

18 Nov 2019

Director

Buy

5,000

$1.45

$7.25K

Megan Sniecinski

18 Nov 2019

Chief Business Officer

Buy

45,000

$1.45

$65.25K

Jon P Stonehouse

18 Nov 2019

President & CEO

Buy

50,000

$1.45

$72.50K

Steve Aselage

22 May 2019

Director

Buy

3,000

$3.57

$10.71K

Steve Aselage

12 Mar 2019

Director

Buy

2,000

$8.30

$16.60K

BIOCRYST PHARMACEUTICALS INC

What the insiders did Net buying

Individual transactions

What was left out